BUSINESS● LOWAug 12 · Aug 12, 2026, 12:32 PM
Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16
Seeking Alpha Tech
Aprea Therapeutics reported GAAP earnings per share of -$0.07, which surpassed analyst expectations. This indicates the company's financial performance relative to forecasts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS31m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech